Use of Obesity Biomarkers in Cardiovascular Epidemiology
Obesity is an established risk factor for cardiovascular disease (CVD), yet, the underlying mechanisms are only poorly understood. The adipose tissue produces a variety of hormones and cytokines and thereby actively participates in a network of biomarkers that may be relevant for the development of...
Main Author: | Tobias Pischon |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2009-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.3233/DMA-2009-0634 |
Similar Items
-
“Obesity paradoxes”: main causes of an “inverse” cardiovascular epidemiology
by: M. A. Druzhilov, et al.
Published: (2018-10-01) -
Rheumatic Diseases and Obesity: Adipocytokines as Potential Comorbidity Biomarkers for Cardiovascular Diseases
by: Rossana Scrivo, et al.
Published: (2013-01-01) -
Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review
by: Melese Linger Endalifer, et al.
Published: (2020-01-01) -
Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction.
by: Harald Jörn Schneider, et al.
Published: (2012-01-01) -
Potentially Useful Biomarkers For Obesity
by: Violeta-Elena Simion, et al.
Published: (2016-11-01)